PMA device
Cardiomems HF Pressure Measurement System
Abbott Medical · System, Hemodynamic, Implantable (MOM, Class III) · First FDA decision May 28, 2014, newest May 2, 2016Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
16
Naming "Cardiomems HF Pressure"
MAUDE reports
0
Brand "Cardiomems HF Pressure", since 2015
PubMed studies
0
Mentioning "Cardiomems HF Pressure"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Cardiomems HF Pressure Measurement System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEMPMA supplement
P100045-S008 · Decided May 2, 2016 · 48 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hemodynamic, implantable (MOM) · Cardiology
- CARDIOMEMS HF PRESSURE MEASUREMENT SYSTEMPMA supplement
P100045-S002 · Decided Jul 10, 2015 · 226 days after receipt · Normal 180 Day Track
Device type: System, hemodynamic, implantable (MOM) · Cardiology
P100045 · Decided May 28, 2014 · 1,260 days after receipt
Device type: System, hemodynamic, implantable (MOM) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Cardiomems HF Pressure", any status and sponsor, newest update first.
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailurePivotal-lookingRecruiting
Abbott Medical DevicesPublic (ABT)
NCT06526195 · 850 participants (planned) · Start Dec 13, 2024 · Primary completion Sep 2029
Device: CardioMEMS HF System; HeartMate 3 Left Ventricular Assist System · For: Heart Failure; Heart Diseases; Cardiovascular Diseases and 1 more
Sites: Phoenix, Arizona; Little Rock, Arkansas; Sacramento, California · 70 sites in all
Centre Hospitalier Universitaire de NīmesAcademic, hospital or other
NCT05428631 · 4 participants · Start Aug 2, 2022 · Primary completion Oct 25, 2023
Device: Implantation of the CARDIOMEMS™ HF device · For: Heart Failure; Renal Insufficiency
Sites: Nîmes, France; Montpellier, France
- CardioMEMS HF System Real-World Evidence Post-Approval StudyEnrolling by invitation
Abbott Medical DevicesPublic (ABT)
NCT06306573 · 2,500 participants (planned) · Start Dec 15, 2022 · Primary completion Dec 31, 2028
Device: CardioMEMS HF System · For: Heart Failure NYHA Class II; Heart Failure NYHA Class III
Sites: Atlanta, Georgia
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Cardiomems HF Pressure", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MOM
12,295 reports: 7,687 malfunction, 4,377 injury, 226 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1427-2025 · Started Feb 3, 2025 · Posted by FDA Mar 21, 2025
Reason given: Due to issues associated with data migration of patient information and results to a Cloud service, the firm has received complaint associated with some patient profile information being duplicated while other patient information is missing.
Cause as FDA categorized it: Software design · Device type: System, Hemodynamic, Implantable (MOM)
Z-0987-2025 · Started Nov 6, 2024 · Posted by FDA Jan 17, 2025
Reason given: Due to a data migration from on-premises server to the cloud environment, some customers reported that they were not able to transmit readings.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Hemodynamic, Implantable (MOM)
Z-0988-2025 · Started Oct 5, 2024 · Posted by FDA Jan 17, 2025
Reason given: As a result of a cloud data migration of Patient and Hospital Electronic Systems (PES and HES) reverted to an outdated configuration causing incorrect/inaccurate pulmonary artery (PA) pressure readings.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Hemodynamic, Implantable (MOM)
10 more recall records with a free account
Published research
The most relevant PubMed records for "Cardiomems HF Pressure"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MOM.
- CardioMEMS HF SystemAbbott Medical · PMA 2026
- Cordella Pulmonary Artery Sensor SystemEndotronix, Inc. · PMA 2026
- Next Gen Patient System CM1200 CardioMEMS HERO DeviceAbbott Medical · PMA 2026
- CorPASS SystemEndotronix, Inc. · PMA 2025
- CardioMEMS patient and hospital electronicsAbbott Medical · PMA 2018
- CardiomemsAbbott Medical · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.